셀러리악 추출물의 암세포 증식 억제 효과
Inhibitory Effect of Celeriac Extract on Cancer Cell Proliferation
0
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
본 연구는 다양한 항암성분을 함유한 Celeriac Extract의 암세포 증식에 미치는 영향을 살펴보기 위하여 실시되었다. 실험에 사용한 암 세포주는 5종으로 폐암세포 A549, 전립샘암세포 DU-145, 자궁암세포 HeLa, 유방암세포 MCF-7, 간암세포 SNU-182 로 모두 인체 유래 암 세포주를 사용하였으며 Celeriac Extract 10ug/mL, 100ug/mL, 1000ug/mL 에 대한 암세포의 증식 억제는 CCK-8 방법을 이용하여 측정하였다. 암세포 증식 억제를 살펴본 결과 Celeriac Extract 1000ug/mL는 폐암세포 A549, 전립샘암세포 DU-145, 자궁암세포 HeLa, 간암세포 SNU-182에서 유의한 증식 억제를 보였으며 농도 의존성을 나타냈다. 그러나 유방암세포 MCF-7 에서는 농도 의존적인 감소만 보였다. 결론적으로, 다양한 인간유래 암 세포주를 이용한 Celeriac Extract의 세포 증식 억제기전들은 암 예방효과 및 치료제 개발의 잠재력을 제공한다고 볼 수 있다.
Abstract
This study was carried out examine the effect of Celeriac Extract, which contains various anticancer ingredients, on the proliferation inhibition of human-derived cancer cells and the degree of inhibition. The five cell lines used in the experiment were lung cancer cells A549, prostate cancer cells DU-145, uterine cancer cells HeLa, breast cancer cells MCF-7, and liver cancer cells SNU-182. All cancer cells derived from the human body were used, and the inhibition of cancer cell proliferation with Celeriac Extract 10ug/mL, 100ug/mL, and 1000ug/mL was measured using the CCK-8 method. As a result of examining the inhibition of cancer cell proliferation, Celeriac Extract 1000ug/mL showed significant proliferation inhibition in lung cancer cells A549, prostate cancer cells DU-145, uterine cancer cells HeLa, and liver cancer cells SNU-182, and showed a concentration dependence. However, only a concentration-dependent decrease was observed in breast cancer cells MCF-7.In conclusion, it can be seen that the cell proliferation inhibition mechanisms of Celeriac Extract using various human-derived cancer cell lines provide the potential for cancer prevention and therapeutic development.
참고문헌 (26)
- B. Rocca, "Cyclooxygenases and prostaglandins shaping up the immune response", Int. Immunopharmacol, 2, pp.603~607 (2002)
- R. L. Siegel, "Cancer statistics", CA Cancer J Clin, 66, pp.7~30 (2016)
- I. Goleberg., "Functional Foods", pp.350~550 (1994), Chapman &Hall Press
- O. Sadaki., "The development of functional foods and material", Bio-industry, 13, pp.44~50 (1996)
- X. Wang, "Fruit and vegetable consumption and mortality from all causes, cardiovascular disease, and cancer : systematic review and dose-response meta-analysis of prospective cohort studies", BMJ, 349 (2014)
- R. C. Garcia, "Intake of specific carotenoids and flavonoids and the risk of gastric cancer in Spain", Cancer Causes Control, 10, pp.71~75 (1999)
- M. Rossi, "Flavonoids and colorectal cancer in Italy", Cancer Epidemiol Biomarkers Prev, 15, pp.1555~1558 (2006)
- C. Bosetti, "Flavonoids and breast cancer risk in Italy", Cancer Epidemiol Biomarkers Prev, 14, pp.805~808 (2005)
- M. A. Gates, "Flavonoid intake and ovarian cancer risk in a population-based case-control study", Int. J. Cancer, 124, pp.1918~1925 (2009)
- P. L. Horn-Ross, "Phytoestrogen intake and endometrial cancer risk", J. Natl. Cancer Inst, 95, pp.1158~1164 (2003)
- C. L. Frankenfeld, "Dietary flavonoid intake and non-Hodgkin lymphoma risk", Am J. Clin Nutr, 87, pp.1439~1445 (2008)
- "Growing Crops: Celery and Celeriac", Urban Organic, ~ (2011)
- H. Chisholm., "Encyclopædia Britannica" (1911), Cambridge University Press
- S. Wolfgang., "Celeriac(Apium graveolens rapaceum)" (2012), Desirable Vegetable Varieties
- W. L. Chen, "Apigenin protects against ischemia-", hypoxia-induced myocardial injury by mediating pyroptosis and apoptosis, 2020, pp.13, 307~312
- P. T. Ana, "The Effect of Apium Nodiflorum in Experimental Osteoporosis", Current Pharmaceutical Biotechnology, 16(5), pp.414~423 (2015)
- 이재혁, "셀러리악 추출물의 LPS로 유도된 전 염증성 사이토카인 생성에 미치는 영향", 한국융합학회논문지, 12(2), pp.295~300 (2021), 한국융합학회[DOI]
- S. F Jin, "XL413, a cell division cycle 7 kinase inhibitor enhanced the anti-fibrotic effect of pirfenidone on TGF-β1-stimulated C3H10T1", 2 cells via Smad2, Exp Cell Res, pp.2015, 339(2)[DOI]
- L. Chunhua, "Apigenin up-regulates transgelin and inhibits invasion and migration of colorectal cancer through decreased phosphorylation of AKT", J. Nutr. Biochem, 24, pp.1766~1775 (2013)
- D. F. Birt, "Anti-mutagenesis and anti-promotion by apigenin, robinetin and indole-3-carbinol", Carcinogenesis, 7, pp.959~963 (1986)
- S. Shukla, "Apigenin inhibits prostate cancer progression in TRAMP mice via targeting PI3K", Akt, Carcinogenesis, pp.2014, 35[DOI]
- S. Shukla, "Apigenin induces apoptosis by targeting inhibitor of apoptosis proteins and Ku70-Bax interaction in prostate cancer", Apoptosis, 19, pp.883~894 (2014)
- B. Mafuvadze, "Apigenin induces apoptosis and blocks growth of medroxyprogesterone acetate-dependent BT-474 xenograft tumors", Horm Cancer, 3, pp.160~171 (2012)
- D. F. Birt, "Anti-mutagenesis and anti-promotion by apigenin, robinetin and indole-3-carbinol", Carcinogenesis, 7, pp.959~963 (1986)
- X. Tong, "Chemopreventive apigenin controls UVB-induced cutaneous proliferation and angiogenesis through HuR and thrombospondin-1", Oncotarget, 5, pp.11413~11427 (2014)
- B. B. Bridgeman, "Inhibition of mTOR by apigenin in UVB-irradiated keratinocytes : A new implication of skin cancer prevention", Cell Signal, 28, pp.460~468 (2016)